Tuesday, October 19, 2021

Tag: Gilead Sciences

CytoDyn Prepares Compelling Argument for Breakthrough Therapy Designation

CytoDyn Inc. (OTCMKTS: CYDY) released its Triple Negative Breast Cancer (TNBC) data in an 8-K filing last week, showcasing leronlimab’s extremely promising future in...